Quality & Compliance

A new class of modern cloud systems promises the next step change in QC productivity and data integrity.

How do we further integrate real-world data into clinical research and approval processes?

What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

It’s December – time for The Medicine Maker to welcome you to 2022’s most innovative new technologies in drug development and manufacturing

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

The PQRI has released new recommendations on E&Ls in parenterals.

As we transition into the endemic phase of the pandemic, companies will have to consider how their mRNA products will be housed and stored.

It’s relatively simple: Follow cGMP, keep your facilities clean, keep vermin out, and don’t sell unapproved products…

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

We dig into the story of Lonza in China, and its new HPAPI expansion in Guangzhou